Sagent

1.PHENYLEPHRINE HCl Injection, USP Recall Information

2.We’re thrilled to keep in touch

3.Anti-Capital Punishment Statement

4.Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals for $21.75 Per Share in All Cash Transaction

5.OXACILLIN for Injection, USP Recall Information

6.OXACILLIN for Injection, USP Recall Information

7.FLUCONAZOLE Injection, USP in 0.9% Sodium Chloride Recall Information

Total 7 result(s) found. Search for [] with Google

www.SagentPharma.com Site Map Privacy Terms of Use for Site(s) Sales Terms & Conditions

The SAGENT logo, SAGENT, SAGENT Pharmaceuticals and PreventIV Measures are registered trademarks of Sagent Pharmaceuticals, Inc.
The Nichi-Iko logo, NICHI-IKO and NIKP are registered trademarks of Nichi-Iko Pharmaceutical Co., Ltd.
© 2021 Sagent Pharmaceuticals, Inc.